Search | IOVS | ARVO Journals

View

Showing 1 – 16 of 16

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Efficacy of Laser Peripheral Iridotomy for the Prevention of Angle Closure: A Randomized Controlled Trial

Mingguang He; Yuzhen Jiang; Shengsong Huang; Dolly Shuo-Teh Chang; Beatriz Munoz; Tin Aung; Paul J Foster; David S Friedman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1784. doi:

ARVO Annual Meeting Abstract July 2019

Macular sensitivity endpoints in geographic atrophy secondary to age-related macular degeneration - exploratory analysis of two parallel randomized phase 3 trials

Dolly Shuo-Teh Chang; Verena Steffen; Simon S. Gao; Jayla Briggs; Christina Rabe; Lee Honigberg; Yasir Jamal Sepah; Daniela Ferrara

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2215. doi:

ARVO Annual Meeting Abstract July 2019

The incidence of acute angle-closure attack in primary angle closure suspect after pharmacologic mydriasis: A randomized controlled trial

David S Friedman; Dolly Shuo-Teh Chang; Paul J Foster; Beatriz Munoz; Tin Aung; Mingguang He

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2823. doi:

ARVO Annual Meeting Abstract June 2017

Laser iridotomy does not result in cataract progression in primary angle closure suspect eyes

Dolly Shuo-Teh Chang; Yuzhen Jiang; Beatriz Munoz; Paul J Foster; Mingguang He; Tin Aung; David S Friedman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5573. doi:

ARVO Annual Meeting Abstract September 2016

The relationship between quantitative pupillometry and estimated ganglion cell counts in patients with glaucoma

Dolly Shuo-Teh Chang; Michael V Boland; Karun Arora; David S Friedman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3303. doi:

ARVO Annual Meeting Abstract September 2016

Prevalence of eye disease and reading difficulty in an inner city elementary school population - Preliminary results from the Baltimore Reading and Eye Disease Study (BREDS)

Megan Collins; Lucy I Mudie; Robert Slavin; Roisin Corcoran; Josephine Owoeye; Dolly Shuo-Teh Chang; Michael Repka; David S Friedman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1536. doi:

ARVO Annual Meeting Abstract April 2011

Circadian Rhythm Patterns in Patients with Advanced Glaucoma

Aaron Y. Lee; Sidney T. Chang; Hugh S. Lin; Melike Pekmezci; Russell N. Van Gelder; Anjali M. Bhorade

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):243. doi:

ARVO Annual Meeting Abstract April 2011

A Comparison Of Visual Acuity, Contrast Sensitivity, And Glare Testing Between Clinic And Home In Patients With And Without Glaucoma

Anjali M. Bhorade; Monica Perlmutter; Brad Wilson; Sidney T. Chang; Melike Pekmezci; Jamie Kambarian; Mae Gordon

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5553. doi:

ARVO Annual Meeting Abstract April 2010

The Impact of Glaucoma Severity on Driving Difficulty

A. M. Bhorade; M. S. Perlmutter; B. S. Wilson; J. D. Kambarian; S. T. Chang; M. Pekmezci; M. O. Gordon

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):943. doi:

ARVO Annual Meeting Abstract April 2010

3-T Diffusion Tensor Imaging of Optic Nerve Changes in Glaucoma

S. T. Chang; J. Xu; K. M. Trinkaus; S.-K. Song; E. M. Barnett

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2711. doi:

ARVO Annual Meeting Abstract April 2009

The Relationship Between Lighting and Clinical Measures of Visual Function at Home and in the Clinic in Normal and Glaucoma Participants

A. M. Bhorade; M. S. Perlmutter; S. T. Chang; M. Pekmezci; B. S. Wilson; J. D. Kambarian; M. O. Gordon

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3776. doi:

ARVO Annual Meeting Abstract May 2008

Self-Reported Perception of Driving Function After Ranibizumab Therapy in Patients With Neovascular Age-Related Macular Degeneration (AMD)

P. H. Win; N. M. Bressler; T. S. Chang; J. T. Fine; C. M. Dolan; J. Ward; ANCHOR Research Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5578. doi:

ARVO Annual Meeting Abstract May 2007

Relationship Between Patient-Reported Visual Function and Visual Acuity in Subjects With Neovascular AMD

E. B. Yu; N. M. Bressler; J. T. Fine; J. F. Ward; C. M. Dolan; T. Klesert; T. S. Chang

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1174. doi:

ARVO Annual Meeting Abstract May 2007

Vision-Related Function After Ranibizumab Treatment by Better- or Worse-Seeing Eye: 24 Month Results From MARINA

I. J. Suner; N. M. Bressler; T. S. Chang; J. T. Fine; C. M. Dolan; J. Ward

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1808. doi:

ARVO Annual Meeting Abstract May 2007

Patient-Reported Visual Function Over 24 Months in Predominantly Classic Neovascular AMD: Results From ANCHOR, a Phase III Trial of Ranibizumab and Verteporfin PDT

S. G. Schwartz; N. M. Bressler; J. T. Fine; C. M. Dolan; E. M. Yu; J. F. Ward; T. S. Chang

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1822. doi:

ARVO Annual Meeting Abstract May 2007

Self-Reported Perception of Driving Function Following Ranibizumab Treatment in Patients With Neovascular AMD

T. S. Chang; N. M. Bressler; J. T. Fine; C. M. Dolan; J. Ward

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1830. doi:

Advertisement